Crispr Therapeutics shares tumble after significant earnings miss
LONDON - Zanaga Iron Ore Company Limited (AIM:ZIOC) has announced that CEO Martin Knauth has exercised options under the company’s long-term incentivization plan. In response, Zanaga will issue 1,500,000 new ordinary shares. These shares are expected to be admitted to trading on the AIM Market of the London Stock Exchange (LON:LSEG) around May 30, 2025, and will rank equally with existing shares.
Following the admission of the new shares, the total number of ordinary shares and voting rights in the company will increase to 832,379,996. This new total share count provides a reference for shareholders to determine if they need to disclose changes in their stake in Zanaga as per the Financial Conduct Authority’s rules.
The issuance of new shares is part of the company’s LTIP, which aims to incentivize key executives and align their interests with those of shareholders. The exercise of these options by the CEO reflects a commitment to the company’s future prospects.
The information contained in this article is based on a press release statement from Zanaga Iron Ore Company Limited.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.